Bach P. [Not Available]. MMW Fortschr Med. 2025 167(5):31.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder. Eur Arch Psychiatry Clin Neurosci. 2025 Mar 12. [Epub ahead of print]
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol-Related Hospitalizations: A Register Study. Acta Psychiatr Scand. 2025 152(2):94-103. Epub 2025 Mar 17.
Baumann G, Fischer R, Reinhard I, Hoffmann S, Kiefer F, Leménager T, Bach P. Investigating decision-making under risk in pathological gambling using a virtual slot machine - a pilot eye-tracking study. Eur Addict Res. 2025 Aug 26. [Epub ahead of print] :1-28.
Bekier N, Frischknecht U, Eidenmueller K, Grimm F, Bach P, Stenger M, Kiefer F, Hermann D. Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients. Eur Arch Psychiatry Clin Neurosci. 2025 275(2):565-572. Epub 2024 Mar 19.
Liu S, Haucke M, Groß R, Schneider K, Shin J, Arntz F, Bach P, Banaschewski T, Beste C, Deserno L, Ebner-Priemer U, Endrass T, Ganz M, Ghadami A, Giurgiu M, Heinz A, Kiefer F, Kliegl R, Lenz B, Marciniak MA, Meyer-Lindenberg A, Neubauer AB, Rapp M, Smolka MN, Strehle J, Spanagel R, Spitta G, Tost H, Walter H, Zech H, Reichert D, Reichert M. Real-time mechanism-based interventions for daily alcohol challenges: Protocol for ecological momentary assessment and intervention. Digit Health. 2025 11:20552076241311731.
Pfisterer M, Teetzmann A, Vetter S, Baeßler J, Schreckenberger L, Zaiser J, Stenger M, Bach P. CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder - a randomized controlled trial. Psychopharmacology (Berl). 2025 Aug 29. [Epub ahead of print]
Pfisterer M, Zimmermann S, Zaiser J, Gerhardt S, Vollstädt-Klein S, Kiefer F, Bach P. Biomarkers in alcohol use disorder - the promise and pitfalls of neuroimaging drug cue reactivity. Biomarkers in neuropsychiatry. 2025 12:100119.
Türkmen C, Machunze N, Lee AM, Bougelet E, Ludin NM, de Cates AN, Vollstädt-Klein S, Bach P, Kiefer F, Andreas JB, Kamphuis J, Schoevers RA, Emslie GJ, Hetrick SE, Viechtbauer W, van Dalfsen JH. Systematic Review and Meta-Analysis: The Association Between Newer Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2025 Jan 17. [Epub ahead of print]
Vetter S, Schnabel S, Reichl M, Sirignano L, Grinevich V, Koopmann A, Spanagel R, Kiefer F, Sommer WH, Bach P. Intranasal oxytocin blunts amygdala response to negative affective stimuli in males and females with alcohol use disorder: a randomized controlled cross-over trial. Psychopharmacology (Berl). 2025 242(9):1995-2007. Epub 2025 Mar 31.
Vetter S, Weinberg J, Thomas BC, Kirchner M, Thalmann P, Klose C, Pfisterer M, Kölsch T, Oesterle S, Vollstädt-Klein S, Koopmann A, Lenz B, Kiefer F, Link T, Bach P. Investigation of the combined effects of cannabidiol plus naltrexone on alcohol craving in alcohol dependence: study protocol of a phase II randomised, double-blind, placebo-controlled, parallel-group trial - ICONICplus Trial. BMJ Open. 2025 15(8):e106348.
Wenzel JG, Reichert M, Zech H, Wedemeyer F, Deeken F, Spitta G, Bach P, Lenz B, Ebner-Priemer UW, Kiefer F, Rapp MA, Walter H, Heinz A, Banaschewski T. One-year ecological momentary assessment of alcohol use, mood, and stress among individuals with alcohol use disorder during SARS-CoV-2 pandemics: a gender-specific reflection. Eur Arch Psychiatry Clin Neurosci. 2025 275(2):451-461. Epub 2024 Nov 19.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Bach P, Koopmann A. Glucose intake reduces alcohol craving and amplifies habituation to cue-induced brain activation in male patients with alcohol use disorder: A randomized, placebo-controlled crossover study examining male and female patients with AUD. Psychoneuroendocrinology. 2025 177:107456.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Koopmann A, Bach P. Glucose Intake Reduces Craving in Patients with Alcohol Use Disorder Depending on Insulin Response. Eur Addict Res. 2025 31(4):251-263.
Zaiser J, Hoffmann S, Zimmermann S, Gessner T, Deck M, Bekier N, Abel M, Radler P, Langejürgen J, Lenz B, Vollstädt-Klein S, Stallkamp J, Kirschbaum C, Kiefer F, Bach P. Individual stress reactivity predicts alcohol craving and alcohol consumption in alcohol use disorder in experimental and real-life settings. Transl Psychiatry. 2025 15(1):226.
Zimmermann S, Teetzmann A, Baeßler J, Schreckenberger L, Zaiser J, Pfisterer M, Stenger M, Bach P. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025 30(6):2612-2619. Epub 2024 Dec 12.